Higher concentrations of lipoprotein(a) have long been associated with atherosclerosis and aortic stenosis, but no drug therapies that lower this concentration are approved. Olpasiran shows promise.
Higher concentrations of lipoprotein(a) have long been associated with atherosclerosis and aortic stenosis, but no drug therapies that lower this concentration are approved. Olpasiran shows promise.
